Corcept Therapeutics Incorporated (CORT)
CORT price $116.53 +0.08 +0.07%
- Ticker
- CORT
- Price
- $116.53
- Change
- +0.08 +0.07%
- Market cap
- $12.60B
- P/E
- 223.94
- Forward P/E
- 57.25
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Stocklytics score
- 34
Corcept Therapeutics Incorporated, founded in 1998 and headquartered in Menlo Park, California, is a pharmaceutical firm dedicated to the discovery, development, and commercialization of treatments for serious metabolic, oncological, and neuropsychiatric disorders across the United States. Its primary commercial offering is Korlym (mifepristone) tablets, an oral medication taken once daily. Korlym is prescribed for…